Filtered By:
Infectious Disease: COVID-19
Education: Education
Therapy: Speech Therapy

This page shows you your search results in order of date.

Order by Relevance | Date

Total 8 results found since Jan 2013.

How John Fetterman Came Out of the Darkness
When he looks back on the past year—a year in which he nearly died, became a U.S. Senator, and nearly died again—it is the debate that John Fetterman identifies as the ­breaking point. “The debate lit the mitch,” he says, then shakes his head in frustration and tries again. The right word is there in his brain, but he struggles to get it out. “Excuse me, that should be lit the mitch—” He stops and tries again. “Lit the match,” he says finally. Oct. 25, 2022: the date is lodged in his mind. “I knew I had to do it,” he tells me. “I knew that the vote...
Source: TIME: Health - July 20, 2023 Category: Consumer Health News Authors: Molly Ball Tags: Uncategorized Congress Cover Story Exclusive feature uspoliticspolicy Source Type: news

Recent trends in telerehabilitation of stroke patients: A narrative review
CONCLUSIONS: The review shows TR is superior or similar to conventional rehabilitation in clinical outcomes and is used as complementary therapy or as alternative treatments. More importantly, TR provides access to rehabilitation services of a large number of patients with immobility, living in remote areas, and during COVID-19 pandemic or similar events.PMID:35527574 | DOI:10.3233/NRE-210330
Source: NeuroRehabilitation - May 9, 2022 Category: Rehabilitation Authors: Vitaly A Nikolaev Alexander A Nikolaev Source Type: research

A Virtual, Randomized, Control Trial of a Digital Therapeutic for Speech, Language, and Cognitive Intervention in Post-stroke Persons With Aphasia
Conclusions: Overall, this study demonstrates the feasibility of a fully virtual trial for patients with post-stroke aphasia, especially given the ongoing COVID19 pandemic, as well as a safe, tolerable, and efficacious digital therapeutic for language/cognitive rehabilitation.Clinical Trial Registration:www.ClinicalTrials.gov, identifier NCT04488029.
Source: Frontiers in Neurology - February 12, 2021 Category: Neurology Source Type: research